Technology Innovator Awards 2021 27 Best Medical Reports Automation Specialists - Europe Image analysis is an important part of the medical profession. Without effective and efficient ways to analyse the data retrieved from a patient, their jobs get so much harder; and so, ascertaining the best ways to do that is a crucial job for medical technology firms. One such company addressing this demand is FUSE AI. Founded in Hamburg, this German firm has dedicated itself to the develop of image analysis algorithms for medical professionals, creating the innovations that are shaping the future of its industry. It offers solutions for everything from detection to the segmentation and classification of medical images, using both traditional image processes and modern machine ‘deep learning’. Initially, the first utilisation of its solutions was the computer assisted analysis of prostate magnetic resonance imaging (MRI). This was carried out with resounding success, and since then, FUSE AI’s efforts to combine social responsibility and economic benefit into intelligent, novel, factual, data-based concepts have been continually lauded as exemplary by its clients. FUSE AI believes that deep customer understanding is the key that has allowed it to do this, striving to serve its partners and clients with services that meet and exceed expectations. In tandem with this, FUSE AI is consistent in keeping its finger on the pulse of its industry; by keeping abreast of new trends, developments, and paradigms, it can ensure its creations are based on the newest and best established technologies in its field. Therefore, it is able to effectively follow its vision of being able to use AI to make predictions about the prognosis of disease. Bettering diagnostic decisions across the board – with accurate and efficient analysis – it can empower physicians to develop individual therapies and treatments for patients at an early stage, reducing the likelihood that person will need urgent hospital care in the near future. According to FUSE AI, the prostate MRI is simply step one. Because it sees its products from the customer’s perspective, it wishes to respond to how their demands shape the sector of med-tech, working to address their needs. Fundamentally, it focuses on high quality data with which to train its neuronal nets to ensure the best diagnostics, allowing Doctors to handle increased workload effectively and patients to be seen in a timely manner. This has been further empowered by the business’s base in Hamburg. The region is a flourishing hub for innovation, with applied AI becoming a vastly competitive field and an important aspect of guiding the future direction of the business, science, and society focused worlds. In addition, FUSE AI has made a name for itself for taking a proactive approach to learning. It works together with universities, companies, and ministries, seeking to keep its knowledge to the highest levels of excellence, and approaching its clients with an agile, adaptive mindset. This is, of course, made possible by its exemplary team; internally, the culture is one of motivation and innovation both as it encourages employees to work towards their own personal and career development. In fostering a company-wide attitude of new ideas, teamwork, problem solving, and communicating, it forges a sturdy foundation of sustainably intense and enthusiastic spirit. As it moves forward into the rest of 2021, FUSE AI plans to submit the documents for certification of its quality management system, alongside its first product adhering to ISO13485 and MDR, after which the market entry of its prostate MRI analysis and market shares will take place. Furthermore, partners and clients alike can look forward to the upcoming establishment of a new research institute that will further advance AI technology’s role in future forms of therapy and genome analysis. Company: FUSE AI Contact: Matthias Steffen Website: www.fuse-ai.de Apr21204 Currently addressing a 520k FDA approval and with the developments of many more products soon to join its flagship innovation, FUSE AI is using machine learning and artificial intelligence to better the accuracy and efficiency of medical imaging analysis. Since its founding in 2017, it has made itself a standout voice championing the role that AI will have in the future of medical technology. It offers solutions for everything from detection to the segmentation and classification of medical images, using both traditional image processes and modern machine ‘deep learning’.
RkJQdWJsaXNoZXIy NTY1MjM3